Guoying Ni

9PUBLICATIONS
17CO-AUTHORS
Medical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursTerrestrial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 24, 2026
Acinetobacter baumannii in the Age of Antimicrobial Resistance: Clinical Impact, Therapeutic Approaches, and Vaccine Development.

|Jun 27, 2025
Synergistic Antitumor Effects of Caerin Peptides and Dendritic Cell Vaccines in a 4T-1 Murine Breast Cancer Model.

Rongmi Mo, Junjie Li, Xinyi Song

|Jan 30, 2025
Caerin 1.1/1.9-mediated antitumor immunity depends on IFNAR-Stat1 signalling of tumour infiltrating macrophage by autocrine IFNα and is enhanced by CD47 blockade.

Junjie Li, Yuandong Luo, Quanlan Fu

|Dec 11, 2022
Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour Macrophages.

Xiaodan Yang, Xiaosong Liu, Junjie Li

|Aug 12, 2022
Preclinical Pharmacokinetics, Biodistribution, and Acute Toxicity Evaluation of Caerin 1.9 Peptide in Sprague Dawley Rats.

Xiaodan Yang, Junjie Li, Shu Chen

|Apr 21, 2022
Caerin 1 Peptides, the Potential Jack-of-All-Trades for the Multiple Antibiotic-Resistant Bacterial Infection Treatment and Cancer Immunotherapy.

Liyin Xiao, Xiaodan Yang, Junjie Li

Pageof 2

Frequent Collaborators

5 joint publications

Xiaosong Liu

4 joint publications

Tianfang Wang

3 joint publications

David Good

3 joint publications

Xiaosong Liu